REQUEST A DEMO
Total
USD $0.00
Search more companies

N.B. Pharma Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: N.B. Pharma Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

N.B. Pharma Company Limited is a company in Thailand, with a head office in Lampang. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on May 14, 2026. There are currently 57 (estimated) people employed by N.B. Pharma Company Limited. The company’s latest financial report indicates a net sales revenue increase of 29.27% in 2024. Over the same period, its total assets grew by 5.14%.

Headquarters
209,211,213-213/1-2 Thip Chang Road
Lampang; Northern Thailand; Postal Code: 52100

Contact Details: Purchase the N.B. Pharma Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the N.B. Pharma Company Limited report to view the information.
Financial Auditors:
Purchase the N.B. Pharma Company Limited report to view the information.
Incorporation Date:
May 14, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after N.B. Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
29.27%
Total Operating Revenue
29.82%
Operating Profit
544.68%
EBITDA
544.68%
Net Profit/Loss for the Period
N/A
Total Assets
5.14%
Total Equity
-1.38%
Operating Profit Margin
0.7%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
99.29%
Quick Ratio
-0.04%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?